Thrombocytopenia during levetiracetam therapy
- PMID: 18424076
- DOI: 10.1016/j.eplepsyres.2008.03.002
Thrombocytopenia during levetiracetam therapy
Abstract
A 64-year-old patient with symptomatic epilepsy developed thrombocytopenia during treatment with levetiracetam (LEV). As no other medical reason could be evaluated, a medication side effect was postulated. The only new drugs were valproic acid (since 3 weeks) and levetiracetam (since 3 days). After valproic acid medication was ended, thrombocytopenia did not improve and even worsened further. Finally levetiracetam administration was ended and trombocytopenia resolved rapidly and completely within few days.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials